There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need ...

The Coronavirus disease 2019 (COVID-19) was identified in late 2019 and has gradually spread to all countries. Following the outspread of this virus as a community-acquired disease, many researchers have been trying to identify various factors involved in the transmission of the virus, as well as the ways to prevent its transmission from person to person. For example, researchers have found tha...

The novel, emerging coronavirus termed as the ‘Severe Acute Respiratory Syndrome (SARS)-related Coronavirus Type 2’ (SARS-CoV-2) is infectious agent responsible for generally mild but somet...

The coronavirus pandemic, known as COVID-19, is caused by severe acute respiratory syndrome 2 (SARS-CoV-2) [...]

In 2019 a newly emerged coronavirus was detected by the Center for disease control (CDC) in China. Nucleic acid sequencing from nose and throat swab samples of patients revealed that it was like severe acute respiratory syndrome coronavirus (SARS-CoV). World Health Organization (WHO) named it coronavirus disease 2019 (COVID-19) and reported more than 100000 positive tests until March 2020 for C...

??? ????????? ?????? ???? ???????? ? ???????????? ?????????????? ?????? ?? ??????????, ??????????? ???????????, ??????? ???????????? ??????????? ?????, ????????? ????????? SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2). ??????????? ????? ????? ????????? ? ?????????? ?????????? ?????? SARSCoV-2 ?????-???????????-??????????????? ??????? (????), ??? ???????? ???????????? ??????, ????...

Introduction: Emerging viral diseases (EVDs) pose a significant threat to public health. There have been a few viral epidemics in the last two decades. Coronavirus disease 2019 (COVID-19) is now a global pandemic.Objective: To provide emergency physicians an update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its dynamic impact on the emergency department (ED) in te...

During the first year of enhanced MERS coronavirus surveillance in England, 77 persons traveling from the Middle East had acute respiratory illness and were tested for the virus. Infection was confirmed in 2 travelers with acute respiratory distress syndrome and 2 of their contacts. Patients with less severe manifestations tested negative.

The coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome 2 (SARS-CoV-2), has induced a global emergency [...]